معرفی
Dr. Harry Shrives is a researcher affiliated with Newcastle University, specializing in biochemical and pharmaceutical research with a focus on kinase inhibitor development. His academic work appears in the university's ePrints repository as a contributor to specialized biochemical studies.
His research interests center on molecular mechanisms of kinase inhibition, particularly in the context of NF-κB signaling pathways. This work bridges medicinal chemistry and cancer therapeutics, with emphasis on covalent modification strategies for targeted drug design.
Dr. Shrives' publication record shows specialization in developing alkynylpyrimidine-based compounds that selectively target cysteine residues in kinases, representing an innovative approach to selective kinase inhibition with potential therapeutic applications.
As a researcher at Newcastle University, he collaborates with colleagues across biochemical disciplines, contributing to the institution's research profile in molecular pharmacology and drug discovery.